Bristol-Myers Squibb Co. v. EMD Serono, Inc.
1:17-cv-01029
Overview
Case Number
1:17-cv-01029
Filing Date
2017-07-26
Status
Litigation filed
Court
District Court, D. Delaware
Nature of Suit
830 Patent
Parties
Defendant
Plaintiff
Court & Judges
Court
District Court, D. Delaware
Presiding Judge
Colm Felix Connolly
Patents Involved
No asserted patent numbers detected in initial docket filings yet.
Docket Entries
COMPLAINT FOR PATENT INFRINGEMENT filed with Jury Demand against EMD Serono, Inc., Merck KGaA, Pfizer Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2190317.) - filed by E.R. Squibb & Sons L.L.C., Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(crb) (Entered: 07/26/2017)
2017-07-26
1
Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (crb) (Entered: 07/26/2017)
2017-07-26
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) U.S. 9,402,899 B2. (crb) (Entered: 07/26/2017)
2017-07-26
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bristol-Myers Squibb Co. for E.R. Squibb & Sons L.L.C. filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Ono Pharmaceutical Co., Ltd. (crb) (Entered: 07/26/2017)
2017-07-26
1
No Summons Issued
2017-07-26
1
No Actions
No Summons Issued. (crb)
2017-07-26
1
No Actions
Case Assigned/Reassigned
2017-08-02
1
No Actions
Case Assigned to Judge Gregory M. Sleet. Please include the initials of the Judge (GMS) after the case number on all documents filed. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS (rjb)
2017-08-02
1
No Actions
STIPULATION TO EXTEND TIME for defendants to move, answer, or otherwise respond to Plaintiffs' complaint to October 4, 2017 - filed by EMD Serono, Inc., Merck KGaA, Pfizer Inc.. (Blumenfeld, Jack) (Entered: 08/07/2017)
2017-08-07
1
SO ORDERED AND ~Util - Set/Reset Answer Deadline
2017-08-07
1
No Actions
SO ORDERED, re 5 STIPULATION TO EXTEND TIME for defendants to move, answer, or otherwise respond to Plaintiffs' complaint to October 4, 2017 filed by EMD Serono, Inc., Pfizer Inc., Merck KGaA, Set/Reset Answer Deadlines: EMD Serono, Inc. answer due 10/4/2017; Merck KGaA answer due 10/4/2017; Pfizer Inc. answer due 10/4/2017. Ordered by Judge Gregory M. Sleet on 8/7/2017. (asw)
2017-08-07
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri, Richard J. McCormick, Manuel J. Velez and Ying-Zi Yang - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Kelly) (Entered: 08/10/2017)
2017-08-10
1
SO ORDERED
2017-08-11
1
No Actions
SO ORDERED, re 6 MOTION for Pro Hac Vice Appearance of Attorney Lisa M. Ferri, Richard J. McCormick, Manuel J. Velez and Ying-Zi Yang filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C. Ordered by Judge Gregory M. Sleet on 8/11/2017. (asw)
2017-08-11
1
No Actions
Add Attorneys - PHV only
2017-08-16
1
No Actions
Add Attorneys - PHV only
2017-08-16
1
No Actions
Add Attorneys - PHV only
2017-08-16
1
No Actions
Add Attorneys - PHV only
2017-08-16
1
No Actions
Pro Hac Vice Attorney Ying-Zi Yang for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-08-16
1
No Actions
Pro Hac Vice Attorney Richard J. McCormick for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-08-16
1
No Actions
Pro Hac Vice Attorney Manuel J. Velez for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-08-16
1
No Actions
Pro Hac Vice Attorney Lisa M. Ferri for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-08-16
1
No Actions
MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Robert B. Wilson, Laura L. Fairneny, and Anastasia M. Fernands - filed by EMD Serono, Inc., Merck KGaA, Pfizer Inc.. (Blumenfeld, Jack) (Entered: 08/29/2017)
2017-08-29
1
SO ORDERED
2017-08-30
1
No Actions
SO ORDERED - re 7 MOTION for Pro Hac Vice Appearance of Attorney Peter J. Armenio, Robert B. Wilson, Laura L. Fairneny, and Anastasia M. Fernands filed by EMD Serono, Inc., Pfizer Inc., Merck KGaA. Ordered by Judge Gregory M. Sleet on 8/30/2017. (mdb)
2017-08-30
1
No Actions
ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd. by Pfizer Inc., Merck KGaA, EMD Serono, Inc., Wyeth LLC, Genetics Institute, LLC. (Attachments: # 1 Exhibit A - F)(Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
1
ANSWER to 1 Complaint, with Jury Demand, COUNTERCLAIM against Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd. by Pfizer Inc., Merck KGaA, EMD Serono, Inc., Wyeth LLC, Genetics Institute, LLC. (Attachments: # 1 Exhibit A - F)(Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
2
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,595,048 B2; 8,168,179 B2; 8,728,474 B2; 9,067,999 B1; 9,073,994 B2; . (Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
1
Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Wyeth LLC for Genetics Institute, LLC; Corporate Parent Pfizer Inc. for Wyeth LLC filed by Genetics Institute, LLC, Pfizer Inc., Wyeth LLC. (Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
1
Disclosure Statement pursuant to Rule 7.1: identifying Other Affiliate E. Merck KG for Merck KGaA; Corporate Parent Merck KGaA for EMD Serono, Inc. filed by EMD Serono, Inc., Merck KGaA. (Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
1
ORDER REGARDING CASE MANAGEMENT IN CIVIL CASES. Signed by Judge Gregory M. Sleet on 10/4/2017. (asw) (Entered: 10/04/2017)
2017-10-04
1
MOTION to Stay - filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
1
OPENING BRIEF in Support re 13 MOTION to Stay filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.Answering Brief/Response due date per Local Rules is 10/18/2017. (Blumenfeld, Jack) (Entered: 10/04/2017)
2017-10-04
1
DECLARATION of Laura L. Fairneny re 13 MOTION to Stay by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit A - K)(Blumenfeld, Jack) Modified on 10/5/2017 (mdb). (Entered: 10/04/2017)
2017-10-04
1
STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendants' Counterclaim and Motion to Stay to November 1, 2017 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Kelly) (Entered: 10/12/2017)
2017-10-12
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2017-10-13
1
No Actions
SO ORDERED - re 16 STIPULATION TO EXTEND TIME for Plaintiffs to respond to Defendants' Counterclaim and Motion to Stay to November 1, 2017 filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C., Set Briefing Schedule: re 13 MOTION to Stay . (Answering Brief due 11/1/2017). Ordered by Judge Gregory M. Sleet on 10/13/2017. (mdb)
2017-10-13
1
No Actions
NOTICE OF SUBSTITUTION OF COUNSEL re Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.: Entry of appearance of attorney Brian E. Farnan. Attorney Richards, Layton &Finger, P.A. terminated. (Farnan, Brian) (Entered: 10/27/2017)
2017-10-27
1
NOTICE of Entry of Appearance of Matthew A. Pearson by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd. (Farnan, Brian) (Entered: 10/27/2017)
2017-10-27
1
MOTION for Pro Hac Vice Appearance of Attorney Dianne B. Elderkin, Steven D. Maslowski, Angela Verrecchio, Rachel Elsby, Melissa Gibson, and Jason Weil - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 10/27/2017)
2017-10-27
1
MOTION to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) Modified on 11/2/2017 (mdb). (Entered: 11/01/2017)
2017-11-01
1
OPENING BRIEF in Support re 20 MOTION to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..Answering Brief/Response due date per Local Rules is 11/15/2017. (Farnan, Brian) Modified on 11/2/2017 (mdb). (Entered: 11/01/2017)
2017-11-01
1
DECLARATION of Matthew Hartman re 21 Opening Brief in Support by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7)(Farnan, Brian) Modified on 11/2/2017 (mdb). (Entered: 11/01/2017)
2017-11-01
1
ANSWERING BRIEF in Opposition re 13 MOTION to Stay filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..Reply Brief due date per Local Rules is 11/8/2017. (Farnan, Brian) (Entered: 11/01/2017)
2017-11-01
1
DECLARATION of Jason Weil re 23 Answering Brief in Opposition by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15)(Farnan, Brian) Modified on 11/2/2017 (mdb). (Entered: 11/01/2017)
2017-11-01
1
ANSWER to 8 Answer to Complaint,, Counterclaim, by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Brian) (Entered: 11/01/2017)
2017-11-01
1
SO ORDERED
2017-11-02
1
No Actions
Add Attorneys - PHV only
2017-11-02
1
No Actions
SO ORDERED - re 19 MOTION for Pro Hac Vice Appearance of Attorney Dianne B. Elderkin, Steven D. Maslowski, Angela Verrecchio, Rachel Elsby, Melissa Gibson, and Jason Weil filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C.. Ordered by Judge Gregory M. Sleet on 11/2/2017. (mdb)
2017-11-02
1
No Actions
Pro Hac Vice Attorney Melissa R. Gibson for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (dmp, )
2017-11-02
1
No Actions
STIPULATION TO EXTEND TIME to file the Joint Status Report to 11/10/2017 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 11/03/2017)
2017-11-03
1
Add Attorneys - PHV only
2017-11-03
1
No Actions
Pro Hac Vice Attorney Rachel Elsby,Dianne B. Elderkin,Jason E. Weil,Angela Verrecchio,Steven D. Maslowski for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2017-11-03
1
No Actions
STIPULATION TO EXTEND TIME for defendants/counterclaim plaintiffs to file their reply brief in support of their Motion to Stay and to file their answering brief in opposition to plaintiffs' Motion to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction to November 15, 2017 and November 22, 2017, respectively - filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Blumenfeld, Jack) (Entered: 11/08/2017)
2017-11-08
1
SO ORDERED
2017-11-08
1
No Actions
SO ORDERED - re (27 in 1:17-cv-01029-GMS) STIPULATION TO EXTEND TIME for defendants/counterclaim plaintiffs to file their reply brief in support of their Motion to Stay and to file their answering brief in opposition to plaintiffs' Motion to Partially Dismiss Counterclaim Plaintiffs' filed by Wyeth LLC, EMD Serono, Inc., Genetics Institute, LLC, Pfizer Inc., Merck KGaA, (23 in 1:17-cv-01028-GMS) STIPULATION TO EXTEND TIME to file the Joint Status Report to 11/10/2017 filed by E. R. Squibb & Sons L.L.C., Bristol-Myers Squibb Co., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. Ordered by Judge Gregory M. Sleet on 11/8/2017. Associated Cases: 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2017-11-08
1
No Actions
SO ORDERED - re 27 STIPULATION TO EXTEND TIME for defendants/counterclaim plaintiffs to file their reply brief in support of their Motion to Stay and to file their answering brief in opposition to plaintiffs' Motion to Partially Dismiss Counterclaim Plaintiffs' filed by Wyeth LLC, EMD Serono, Inc., Genetics Institute, LLC, Pfizer Inc., Merck KGaA. Ordered by Judge Gregory M. Sleet on 11/8/2017. (mdb)
2017-11-08
1
No Actions
Joint STATUS REPORT by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 11/10/2017)
2017-11-10
1
PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 11/10/2017)
2017-11-10
1
Letter to The Honorable Gregory M. Sleet from Brian E. Farnan regarding Combined Scheduling Conference. (Farnan, Brian) (Entered: 11/10/2017)
2017-11-10
1
NOTICE OF SERVICE of Plaintiffs' First Set of Requests for Production (Nos. 1-88) to Defendants filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 11/14/2017)
2017-11-14
1
REPLY BRIEF re 13 MOTION to Stay filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Blumenfeld, Jack) (Entered: 11/15/2017)
2017-11-15
1
Supplemental DECLARATION of Laura L. Fairneny re 32 Reply Brief by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit L - R)(Blumenfeld, Jack) Modified on 11/16/2017 (mdb). (Entered: 11/15/2017)
2017-11-15
1
STIPULATION TO EXTEND TIME for Plaintiffs to file their Reply Brief in support of their Motion to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction to 12/6/2017 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 11/21/2017)
2017-11-21
1
Oral Order
2017-11-21
1
No Actions
ORAL ORDER - Upon review of the joint status reports filed in these cases, the parties shall file a single joint status report and proposed schedule within 14 days of this order. Although these cases are not consolidated, a single joint status report is most efficient for the court in reviewing the submission. Ordered by Judge Gregory M. Sleet on 11/21/2017. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2017-11-21
1
No Actions
[SEALED] ANSWERING BRIEF in Opposition re 20 MOTION to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.Reply Brief due date per Local Rules is 11/29/2017. (Blumenfeld, Jack) (Entered: 11/22/2017)
2017-11-22
1
[SEALED] DECLARATION of Laura L. Fairneny re 35 Answering Brief in Opposition by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit A - D)(Blumenfeld, Jack) Modified on 11/27/2017 (mdb). (Entered: 11/22/2017)
2017-11-22
1
SO ORDERED AND ~Util - Set Briefing Schedule - open,ans,reply,surreply
2017-11-28
1
No Actions
SO ORDERED - re 34 STIPULATION TO EXTEND TIME for Plaintiffs to file their Reply Brief in support of their Motion to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction to 12/6/2017 filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C., Set Briefing Schedule: re 20 MOTION to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction. (Reply Brief due 12/6/2017). Ordered by Judge Gregory M. Sleet on 11/28/2017. (mdb)
2017-11-28
1
No Actions
REDACTED VERSION of 35 Answering Brief in Opposition, by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Blumenfeld, Jack) (Entered: 11/29/2017)
2017-11-29
1
REDACTED VERSION of 36 Declaration, by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC. (Attachments: # 1 Exhibit A - D)(Blumenfeld, Jack) (Entered: 11/29/2017)
2017-11-29
1
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 12/01/2017)
2017-12-01
1
NOTICE OF SERVICE of Plaintiffs and Counterclaim Defendants' Initial Disclosures filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 12/01/2017)
2017-12-01
1
Joint STATUS REPORT by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Proposed Scheduling Order)(Farnan, Brian) (Entered: 12/05/2017)
2017-12-05
1
REPLY BRIEF re 20 MOTION to Partially Dismiss Counterclaim Plaintiffs' License Counterclaim for Lack of Subject Matter Jurisdiction filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 12/06/2017)
2017-12-06
1
Oral Order AND ~Util - Set Deadlines/Hearings
2017-12-12
1
No Actions
ORAL ORDER re (23 in 1:17-cv-01027-GMS, 31 in 1:17-cv-01028-GMS, 41 in 1:17-cv-01029-GMS) Joint Status Report - A Scheduling Conference is set for Thursday, December 21, 2017 at 10:00 AM (EST) in Courtroom 4A. Ordered by Judge Gregory M. Sleet on 12/12/2017. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2017-12-12
1
No Actions
Oral Order
2017-12-18
1
No Actions
ORAL ORDER RESCHEDULING CONFERENCE re (23 in 1:17-cv-01027-GMS, 31 in 1:17-cv-01028-GMS, 41 in 1:17-cv-01029-GMS, Joint Status Report): - The Scheduling Conference previously set for Thursday, December 21, 2017 at 10:00 AM (EST) in Courtroom 4A has been RESCHEDULED to Thursday, January 25, 2018 at 10:00 AM. Ordered by Judge Gregory M. Sleet on 12/18/2017. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(asw)
2017-12-18
1
No Actions
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Objections and Responses to Plaintiffs and Counterclaim Defendants' First Set of Requests for Production filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 12/29/2017)
2017-12-29
1
Oral Order AND ~Util - Set Deadlines/Hearings
2018-01-09
1
No Actions
ORAL ORDER - The Scheduling Conference previously set to begin at 10:00 AM (EST) in Courtroom 4A on Thursday, January 25, 2018, at 10:00 AM will now begin at 9:30 AM. Ordered by Judge Gregory M. Sleet on 1/9/2018. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS. Ordered by Judge Gregory M. Sleet. (ctd)
2018-01-09
1
No Actions
1 - Terminate Deadlines and Hearings AND Oral Order AND ~Util - Set Deadlines/Hearings
2018-01-22
1
No Actions
ORAL ORDER - The Scheduling Conference previously set for Thursday, January 25, 2018, at 9:30 AM (EST) in Courtroom 4A has been RESCHEDULED to Wednesday, January 24, 2018, at 2:00 PM (EST) in Courtroom 4A. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS. Ordered by Judge Gregory M. Sleet on 1/22/2018. (ctd)
2018-01-22
1
No Actions
Scheduling Conference
2018-01-24
1
No Actions
Minute Entry for proceedings held before Judge Gregory M. Sleet - Scheduling Conference held on 1/24/2018. Discussion and arguments regarding consolidation, the motion to stay filed in the '1029 case, and the schedule. The parties came to an agreement on the schedule and were assigned the following dates: The Markman Hearing (full day) is scheduled for 12/3/2018 at 9:30 AM in Courtroom 4A, the Final Proposed Pretrial Order is due by the close of business on 3/27/2020, the Final Pretrial Conference is set for 4/13/2020 at 10:00 AM in Courtroom 4A, and a 7-day Jury Trial is set for 5/4/2020 at 9:30 AM in Courtroom 4A. These cases are referred to the Magistrate Judge for the purpose of exploring ADR. The plaintiffs shall file an amended proposed scheduling order within 2 weeks from today. (Court Reporter Kevin Maurer.) Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2018-01-24
1
No Actions
PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Letter to The Honorable Gregory M. Sleet)(Farnan, Brian) (Entered: 01/31/2018)
2018-01-31
1
SO ORDERED AND Scheduling Order - Patent
2018-02-02
1
No Actions
SO ORDERED - re (44 in 1:17-cv-01029-GMS, 28 in 1:17-cv-01027-GMS, 33 in 1:17-cv-01028-GMS) Proposed Scheduling Order. Cases referred to the Magistrate Judge for the purpose of exploring ADR. Motions to Join Parties and to Amend Pleadings due by 5/4/2018., Claim Construction Opening Briefs due by 9/28/2018., Claim Construction Answering Briefs due by 11/2/2018., A Markman Hearing (full day) is set for 12/3/2018 at 9:30 AM in Courtroom 4A., Fact Discovery completed by 3/29/2019., Opening Expert Reports due by 5/17/2019., Rebuttal Expert Reports due by 6/28/2019., Reply Expert Reports due by 7/26/2019., Expert Discovery due by 10/16/2019., Opening Summary Judgment Letter Briefs due by 11/1/2019., Answering Letter Briefs due 11/15/2019., Reply Letter Briefs due 11/26/2019., Proposed Pretrial Order due by 3/27/2020., A Final Pretrial Conference is set for 4/13/2020 at 10:00 AM in Courtroom 4A., and a 7-day Jury Trial is set for 5/4/2020 at 9:30 AM in Courtroom 4A. See proposed scheduling order for complete schedule. Ordered by Judge Gregory M. Sleet on 2/2/2018. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2018-02-02
1
No Actions
Case Referred to Mediation - Magistrate Judge only
2018-02-05
1
No Actions
CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at http://www.ded.uscourts.gov/general-orders/magistrate-judges-standing-order-adr-mediation Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(cak)
2018-02-05
1
No Actions
Official Transcript of Conference held on 01 24 18 before Judge Sleet. Court Reporter/Transcriber Maurer. Transcript may be viewed at the court public terminal or purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date it may be obtained through PACER. Redaction Request due 2/27/2018. Redacted Transcript Deadline set for 3/9/2018. Release of Transcript Restriction set for 5/7/2018. (kjm) (Entered: 02/06/2018)
2018-02-06
1
ORDER Setting Teleconference: Plaintiffs' counsel to initiate the call. A Telephone Conference is set for 3/5/2018 at 11:30 AM Eastern Time before Judge Mary Pat Thynge to discuss ADR. Signed by Judge Mary Pat Thynge on 2/8/18. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(cak) (Entered: 02/08/2018)
2018-02-08
1
NOTICE OF SERVICE of Plaintiffs' Paragraph 4a Disclosures filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 02/23/2018)
2018-02-23
1
STIPULATION TO EXTEND TIME to file a Protective Order to April 4, 2018 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Michael) (Entered: 03/02/2018)
2018-03-02
1
ORDER: A teleconference regarding mediation was held on 3/5/18 in these cases. As a result, IT IS ORDERED on or before 3/21/18, each party or each party group shall email to Chief Magistrate Judge Thynge, with a copy to her Judicial Administrator,Cathleen Kennedy, the information requested in this Order. SEE ORDER FOR DETAILS. Signed by Judge Mary Pat Thynge on 3/6/18. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(cak) (Entered: 03/06/2018)
2018-03-06
1
SO ORDERED
2018-03-06
1
No Actions
SO ORDERED - re (35 in 1:17-cv-01027-GMS, 48 in 1:17-cv-01029-GMS, 38 in 1:17-cv-01028-GMS) STIPULATION TO EXTEND TIME to file a Protective Order to April 4, 2018 filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C. Ordered by Judge Gregory M. Sleet on 3/6/2018. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2018-03-06
1
No Actions
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 03/23/2018)
2018-03-23
1
NOTICE OF SERVICE of Plaintiffs and Counterclaim Defendants' Paragraph 3 Disclosures filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 03/23/2018)
2018-03-23
1
NOTICE of Subsequent Activity by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC (Attachments: # 1 Exhibit A & B)(Blumenfeld, Jack) (Entered: 03/26/2018)
2018-03-26
1
STIPULATION TO EXTEND TIME to EXTEND the deadline to file a Proposed Protective Order to 5/4/2018 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Michael) (Entered: 04/02/2018)
2018-04-02
1
SO ORDERED
2018-04-03
1
No Actions
SO ORDERED - re 53 STIPULATION TO EXTEND TIME to EXTEND the deadline to file a Proposed Protective Order to 5/4/2018 filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C.. Ordered by Judge Gregory M. Sleet on 4/3/2018. (mdb)
2018-04-03
1
No Actions
NOTICE OF SERVICE of (1) Defendants and Counterclaim Plaintiffs' Amended Initial Disclosures Pursuant to Federal Rule of Civil Procedure 26(a)(1) and (2) Defendants and Counterclaim Plaintiffs' Supplemental Initial Disclosures Pursuant to Paragraph 3 of the Default Standard for Discovery filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 04/04/2018)
2018-04-04
1
MOTION for Pro Hac Vice Appearance of Attorney Matthew George Hartman and Jenna Marie Pellecchia - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 04/10/2018)
2018-04-10
1
SO ORDERED
2018-04-11
1
No Actions
SO ORDERED - re (41 in 1:17-cv-01027-GMS, 46 in 1:17-cv-01028-GMS) MOTION for Pro Hac Vice Appearance of Attorney Matthew George Hartman, Melissa Gibson, Jenna Pellecchia, and Jason Weil filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C., (55 in 1:17-cv-01029-GMS) MOTION for Pro Hac Vice Appearance of Attorney Matthew George Hartman and Jenna Marie Pellecchia filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C.. Ordered by Judge Gregory M. Sleet on 4/11/2018. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb)
2018-04-11
1
No Actions
Add Attorneys - PHV only
2018-04-12
1
No Actions
Pro Hac Vice Attorney Matthew G Hartman for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (lmm)
2018-04-12
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Initial Infringement Chart filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Ono Pharmaceutical Co., Ltd..(Farnan, Brian) (Entered: 04/25/2018)
2018-04-25
1
STIPULATION TO EXTEND TIME to EXTEND the deadline to file a Proposed Protective Order to 5/18/2018 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 05/04/2018)
2018-05-04
1
SO ORDERED, re 57 STIPULATION TO EXTEND TIME to EXTEND the deadline to file a Proposed Protective Order to 5/18/2018 filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C. Ordered by Judge Gregory M. Sleet on 5/4/2018. (asw)
2018-05-04
1
No Actions
PROPOSED ORDER Proposed Protective Order by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 05/17/2018)
2018-05-17
1
SO ORDERED - re 58 Proposed Protective Order filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C.. Ordered by Judge Gregory M. Sleet on 5/18/2018. (mdb)
2018-05-18
1
No Actions
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Initial Invalidity Contentions filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 06/01/2018)
2018-06-01
1
Pro Hac Vice Attorney Jenna M. Pellecchia for Bristol-Myers Squibb Co. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(ceg)
2018-06-14
1
No Actions
NOTICE OF SERVICE of Plaintiffs' Disclosure of Proposed Claim Terms for Construction filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 07/13/2018)
2018-07-13
1
NOTICE OF SERVICE of First Set of Requests for the Production of Documents and Things to Plaintiffs and Counterclaim Defendants (Nos. 1-80) filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 08/14/2018)
2018-08-14
1
STIPULATION TO EXTEND TIME to Amend Case Schedule to Various Dates - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Michael) (Entered: 08/16/2018)
2018-08-16
1
SO ORDERED, re (53 in 1:17-cv-01028-GMS, 49 in 1:17-cv-01027-GMS, 62 in 1:17-cv-01029-GMS) STIPULATION TO EXTEND TIME to Amend Case Schedule to Various Dates. Set/Reset Scheduling Order Deadlines: (Claim Construction Opening Briefs due by 11/15/2018., Claim Construction Answering Briefs due by 1/24/2019., A Markman Hearing (3 hours) is set for 3/12/2019 at 09:30 AM. Fact Discovery completed by 6/5/2019., Opening Expert Reports due by 7/2/2019., Rebuttal Expert Reports due by 8/5/2019., Expert Discovery due by 8/30/2019. See Stipulation for more details). Signed by Judge Gregory M. Sleet on 8/24/2018. Associated Cases: 1:17-cv-01027-GMS, 1:17-cv-01028-GMS, 1:17-cv-01029-GMS(mdb) (Entered: 08/24/2018)
2018-08-24
1
NOTICE OF SERVICE of Plaintiffs' Disclosure of Proposed Constructions for Claim Terms filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 08/24/2018)
2018-08-24
1
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Preliminary Proposed Claim Constructions filed by EMD Serono, Inc., Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 08/24/2018)
2018-08-24
1
NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Pfizer Inc., Wyeth LLC, Genetics Institute, LLC, EMD Serono, Inc., and Merck KGaA's First Set of Requests for Production to Plaintiffs and Counterclaim Defendants (Nos. 1-80) filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Michael) (Entered: 09/13/2018)
2018-09-13
1
ORAL ORDER: Pursuant to the reassignment of this action, the parties shall submit a joint status report on or before October 4, 2018. Please identify in the status report the next event the parties believe the Court needs to schedule. (Status report due 10/4/2018.) Ordered by Judge Colm F. Connolly on September 20, 2018. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(nmf)
2018-09-20
1
No Actions
Case reassigned to Judge Colm F. Connolly. Please include the initials of the Judge (CFC) after the case number on all documents filed. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC (rjb)
2018-09-20
1
No Actions
STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to 10/5/2018 - filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 09/27/2018)
2018-09-27
1
SO ORDERED, re (67 in 1:17-cv-01029-CFC, 58 in 1:17-cv-01028-CFC, 53 in 1:17-cv-01027-CFC) STIPULATION TO EXTEND TIME to file the Joint Claim Construction Chart to 10/5/2018 filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., Tasuku Honjo, E.R. Squibb & Sons L.L.C. Signed by Judge Colm F. Connolly on 9/28/2018. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(fms)
2018-09-28
1
No Actions
Letter to The Honorable Colm F. Connolly from Brian E. Farnan regarding Joint Status Report. (Farnan, Brian) (Entered: 10/04/2018)
2018-10-04
1
CLAIM Construction Chart by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 10/05/2018)
2018-10-05
1
NOTICE OF SERVICE of (i) Plaintiffs' First Set of Interrogatories (Nos. 1-13) to Defendants and (ii) Plaintiffs' Second Set of Requests for Production (Nos. 89-126) to Defendants filed by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd..(Farnan, Brian) (Entered: 10/08/2018)
2018-10-08
1
ORAL ORDER, On or before Friday, November 9, 2018, the parties shall submit a proposed scheduling order incorporating the dates and discovery limitations currently in effect using the Court's patent form scheduling order: http://www.ded.uscourts.gov/judge/judge-colm-f-connolly. Ordered by Judge Colm F. Connolly on 11/5/2018. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(nmf)
2018-11-05
1
No Actions
PROPOSED ORDER Proposed Scheduling Order by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Farnan, Michael) (Entered: 11/09/2018)
2018-11-09
1
CLAIM Construction Chart by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Exhibit C, # 2 Exhibit D, # 3 Exhibit E, # 4 Exhibit F, # 5 Exhibit G, # 6 Exhibit H, # 7 Exhibit I, # 8 Exhibit J, # 9 Exhibit K, # 10 Exhibit L, # 11 Exhibit M, # 12 Exhibit N, # 13 Exhibit O, # 14 Exhibit P, # 15 Exhibit Q, # 16 Exhibit R, # 17 Exhibit S, # 18 Exhibit T, # 19 Exhibit U, # 20 Exhibit V, # 21 Exhibit W, # 22 Exhibit X, # 23 Exhibit Y, # 24 Exhibit Z, # 25 Exhibit AA, # 26 Exhibit BB, # 27 Exhibit CC, # 28 Exhibit DD, # 29 Exhibit EE, # 30 Exhibit FF, # 31 Exhibit GG, # 32 Exhibit HH)(Farnan, Michael) (Entered: 11/16/2018)
2018-11-16
1
Set Hearings: An In-Court Conference is set for 11/19/2018 at 03:00 PM in Courtroom 4B before Judge Colm F. Connolly Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(nmf)
2018-11-16
1
No Actions
NOTICE of Subsequent Activity by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC re 13 MOTION to Stay (Attachments: # 1 Exhibit A)(Blumenfeld, Jack) (Entered: 11/19/2018)
2018-11-19
1
NOTICE of Subsequent Activity by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC re 13 MOTION to Stay (Attachments: # 1 Exhibit A)(Blumenfeld, Jack) (Entered: 11/19/2018)
2018-11-19
2
Minute Entry for proceedings held before Judge Colm F. Connolly - Scheduling Conference held on 11/19/2018. (Court Reporter V. Gunning.) Counsel to submit the final revised proposed scheduling order to the Court. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(nmf)
2018-11-19
1
No Actions
ORAL ORDER, Having reviewed carefully the briefs filed in support of and in opposition to Defendants' motion to stay (D.I. 13 ) and heard argument from the parties regarding the same at the hearing convened by the Court on November 19, 2018; and recognizing that the circumstances relevant to the motion (including the progress of discovery in and procedural postures of both this action and the District of Massachusetts action) are different today than they were when the motion was filed; and for the reasons discussed by the Court during the November 19, 2018 hearing; it is ORDERED that Defendants' motion to stay (D.I. 13 ) is DENIED. Ordered by Judge Colm F. Connolly on 11/20/2018. (nmf)
2018-11-20
1
No Actions
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Objections and Responses to Plaintiffs' Second Set of Requests for Production (Nos. 89-126) to Defendants filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 11/21/2018)
2018-11-21
1
ORAL ORDER, Whereas at the November 19, 2018 hearing the Court directed the parties to submit a proposed revised scheduling order that incorporates the dates, discovery limitations, and page limitations for claim construction briefing that are currently in effect, the parties are hereby ORDERED to file by December 12, 2018 the proposed revised scheduling order. Ordered by Judge Colm F. Connolly on 12/6/2018. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(nmf)
2018-12-06
1
No Actions
PROPOSED ORDER Proposed Second Amended Scheduling Order by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Attachments: # 1 Letter to The Honorable Colm F. Connolly)(Farnan, Brian) (Entered: 12/10/2018)
2018-12-10
1
SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Discovery due by 8/22/2019. Dispositive Motions due by 2/4/2020. Answering Brief due 3/3/2020. Reply Brief due 3/19/2020. A Markman Hearing is set for 5/29/2019 at 09:00 AM in Courtroom 4B before Judge Colm F. Connolly. Jury Instructions, Voir Dire, Special Verdict Forms and Proposed Pretrial Order due by 9/30/2020. A Final Pretrial Conference is set for 10/8/2020 at 04:30 PM in Courtroom 4B before Judge Colm F. Connolly. A Jury Trial is set for 10/19/2020 at 09:30 AM in Courtroom 4B before Judge Colm F. Connolly. Signed by Judge Colm F. Connolly on 12/12/2018. Associated Cases: 1:17-cv-01027-CFC, 1:17-cv-01028-CFC, 1:17-cv-01029-CFC(nmf) (Entered: 12/12/2018)
2018-12-12
1
NOTICE OF SERVICE of Defendants and Counterclaim Plaintiffs' Objections and Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-13) filed by EMD Serono, Inc., Genetics Institute, LLC, Merck KGaA, Pfizer Inc., Wyeth LLC.(Blumenfeld, Jack) (Entered: 12/19/2018)
2018-12-19
1
PROPOSED ORDER Proposed Amended Protective Order by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Tasuku Honjo, Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 01/15/2019)
2019-01-15
1
AMENDED PROTECTIVE ORDER. Signed by Judge Colm F. Connolly on 1/15/2019. (fms) (Entered: 01/16/2019)
2019-01-16
1
STIPULATION of Dismissal by Bristol-Myers Squibb Co., E.R. Squibb & Sons L.L.C., Ono Pharmaceutical Co., Ltd.. (Farnan, Brian) (Entered: 02/06/2019)
2019-02-06
1
SO ORDERED, re 80 Stipulation of Dismissal filed by Bristol-Myers Squibb Co., Ono Pharmaceutical Co., Ltd., E.R. Squibb & Sons L.L.C., (CASE CLOSED). Signed by Judge Colm F. Connolly on 2/8/2019. (nmf) (Entered: 02/12/2019)
2019-02-12
1
Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,402,899 B2. (Attachments: # 1 Signed Stipulation of Dismissal)(nmf) (Entered: 02/12/2019)
2019-02-12
1